Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH: Antibiotic ban would compromise animal welfare
pill
Access to antimicrobials is necessary to the safeguarding of animal health and welfare, says NOAH.
Briefing paper warns MPs against restricting or banning medicines

Restricting or banning the use of certain antimicrobials in veterinary medicine would compromise animal welfare and may even encourage resistance, NOAH has warned in a briefing paper to MPs.

The paper has been produced to inform MPs following NOAH's attendance at the recent All Party Parliamentary Group on Antibiotics meeting.

In the 12-page report, NOAH insists that access to a range of antimicrobials is necessary to vets and farmers in preserving animal health and welfare, and in fact, limiting the available classes of drugs may promote resistance by putting pressure on the remaining medicines.

Furthermore, the treatment of bacterial infections is required to meet both national and European animal welfare legislation, and is a professional obligation for vets.

NOAH warns that lobby groups who are opposed to the use of antimicrobials in farming risk undoing the good work of the majority of vets and farmers who use medicines responsibly.

Scientific evidence quoted in the paper suggests antibiotic resistance in humans is primarily due to usage in human medicine, rather than in the veterinary sector.

Authors say: “”Restricting the use of antibiotics in animals with the intention of stopping resistance in humans is based on a false hypothesis and may not help but it could compromise the vet's ability to deal with animal disease challenges and cause unnecessary welfare issues for both food production animals and companion animals.

“It could also lead to higher animal mortality and impact on food chain productivity.”

According to the authors, the best method for addressing resistance in the veterinary sector is a combination of responsible use (in terms of biosecurity, good housing and nutrition, appropriate vaccinations, herd health plans and correct use of antibiotics prescribed by a vet) and transparency of use phase.

Under transparency of use, the vet or farmer must supply data on antibiotic use by farm to the authorities. The intensity of use on each farm can then be compared to similar farms in the region, and the authorities can intervene if necessary.

The report states: “It would be an excellent outcome if we have agreement to put Responsible Use and Transparency at the Use Phase into action across the UK and indeed the whole EU at the earliest opportunity.”

NOAH says this would be more appropriate than introducing a blanket ban on usage.

View the full briefing paper here: www.noah.co.uk/papers

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.